MedTrace Logo

HerpeSelect® Express Rapid Test Study Protocol: Sexually Active Adult Population

NCT00655434 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 400

Last updated 2009-01-09

No results posted yet for this study

Summary

This study is designed to compare the performance of the Focus Diagnostics' HerpeSelect® Express, a Herpes Simplex Virus 2 Rapid Test, to a currently marketed device. The intent is to show the rapid test device is comparable to the currently marketed device. HerpeSelect® Express is a rapid test intended for qualitatively detecting the presence or absence of human IgG class antibodies to herpes simplex virus type 2 (HSV-2) in human whole blood (capillary).

Conditions

  • Herpes Simplex Virus 2

Sponsors & Collaborators

  • Focus Diagnostics, Inc.

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-03-31
Primary Completion
2008-05-31
Completion
2008-05-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00655434 on ClinicalTrials.gov